

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.19703062 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.11560132 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.52305996 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.52305996 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.10900161 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.91430374 |
| 7 | negative thymic T cell selection (GO:0045060) | 4.88615900 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.79961890 |
| 9 | negative T cell selection (GO:0043383) | 4.77401871 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.73546463 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.73380304 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.72886610 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69861556 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.69818528 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.66151002 |
| 16 | response to interleukin-15 (GO:0070672) | 4.61796783 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.58869000 |
| 18 | thymic T cell selection (GO:0045061) | 4.53115320 |
| 19 | synaptic vesicle maturation (GO:0016188) | 4.52770371 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.45248563 |
| 21 | leukocyte aggregation (GO:0070486) | 4.36440028 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 4.25741274 |
| 23 | positive T cell selection (GO:0043368) | 4.23244539 |
| 24 | locomotory exploration behavior (GO:0035641) | 4.15630907 |
| 25 | T cell selection (GO:0045058) | 4.13533808 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 4.07717265 |
| 27 | positive regulation of granulocyte differentiation (GO:0030854) | 4.05523596 |
| 28 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.03120874 |
| 29 | Peyers patch development (GO:0048541) | 4.03120874 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.01791905 |
| 31 | vocalization behavior (GO:0071625) | 3.99249968 |
| 32 | cellular response to interleukin-15 (GO:0071350) | 3.97091481 |
| 33 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.92599124 |
| 34 | glutamate secretion (GO:0014047) | 3.89073929 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.80405387 |
| 36 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.79358812 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.78242685 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74981259 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.68661873 |
| 40 | protein localization to synapse (GO:0035418) | 3.67581083 |
| 41 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.65191088 |
| 42 | activated T cell proliferation (GO:0050798) | 3.64926981 |
| 43 | neuronal action potential propagation (GO:0019227) | 3.61686036 |
| 44 | tolerance induction (GO:0002507) | 3.61160527 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.59126460 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.55320373 |
| 47 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.55153026 |
| 48 | T cell migration (GO:0072678) | 3.54777092 |
| 49 | neuron cell-cell adhesion (GO:0007158) | 3.54313159 |
| 50 | dosage compensation (GO:0007549) | 3.54103259 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51504428 |
| 52 | regulation of synaptic vesicle transport (GO:1902803) | 3.48646596 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 3.46995985 |
| 54 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.43018330 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 3.40300920 |
| 56 | dendritic spine morphogenesis (GO:0060997) | 3.38664158 |
| 57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.36732354 |
| 58 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.34215736 |
| 59 | proline transport (GO:0015824) | 3.34061812 |
| 60 | exploration behavior (GO:0035640) | 3.32748627 |
| 61 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.30383212 |
| 62 | sodium ion export (GO:0071436) | 3.30289294 |
| 63 | regulation of granulocyte differentiation (GO:0030852) | 3.29127914 |
| 64 | regulation of defense response to virus by virus (GO:0050690) | 3.28745722 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.28384488 |
| 66 | neurotransmitter secretion (GO:0007269) | 3.26741291 |
| 67 | membrane depolarization during action potential (GO:0086010) | 3.26200199 |
| 68 | cell communication by electrical coupling (GO:0010644) | 3.25408959 |
| 69 | mannose metabolic process (GO:0006013) | 3.24976904 |
| 70 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.23357986 |
| 71 | natural killer cell differentiation (GO:0001779) | 3.21614889 |
| 72 | activation of protein kinase A activity (GO:0034199) | 3.19446173 |
| 73 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.16402592 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.16402592 |
| 75 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.15694067 |
| 76 | cellular potassium ion homeostasis (GO:0030007) | 3.15629303 |
| 77 | detection of bacterium (GO:0016045) | 3.14675601 |
| 78 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.13937281 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 3.08892395 |
| 80 | detection of calcium ion (GO:0005513) | 3.08745484 |
| 81 | cell communication involved in cardiac conduction (GO:0086065) | 3.07685662 |
| 82 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.07104972 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.06884870 |
| 84 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04200921 |
| 85 | megakaryocyte development (GO:0035855) | 3.03137627 |
| 86 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.02604314 |
| 87 | detection of other organism (GO:0098543) | 3.02439763 |
| 88 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.01171340 |
| 89 | neuromuscular process controlling posture (GO:0050884) | 3.00150353 |
| 90 | signal complex assembly (GO:0007172) | 3.00096647 |
| 91 | germinal center formation (GO:0002467) | 2.96990408 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95770081 |
| 93 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.94803066 |
| 94 | neutrophil activation involved in immune response (GO:0002283) | 2.93040405 |
| 95 | synaptic transmission, glutamatergic (GO:0035249) | 2.92894345 |
| 96 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.92562605 |
| 97 | positive regulation of interleukin-4 production (GO:0032753) | 2.92154026 |
| 98 | vesicle transport along microtubule (GO:0047496) | 2.91477536 |
| 99 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.90962339 |
| 100 | regulation of histone H3-K27 methylation (GO:0061085) | 2.90648785 |
| 101 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.89754249 |
| 102 | dendrite morphogenesis (GO:0048813) | 2.89139458 |
| 103 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.88809991 |
| 104 | neuron recognition (GO:0008038) | 2.87977893 |
| 105 | oxygen transport (GO:0015671) | 2.87043563 |
| 106 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87022363 |
| 107 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87022363 |
| 108 | modulation by symbiont of host immune response (GO:0052553) | 2.87022363 |
| 109 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87022363 |
| 110 | modulation by symbiont of host defense response (GO:0052031) | 2.87022363 |
| 111 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87022363 |
| 112 | leukocyte degranulation (GO:0043299) | 2.86763922 |
| 113 | cell migration in hindbrain (GO:0021535) | 2.85607522 |
| 114 | neurotransmitter transport (GO:0006836) | 2.83790721 |
| 115 | glutamate receptor signaling pathway (GO:0007215) | 2.83523006 |
| 116 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.83416332 |
| 117 | transmission of nerve impulse (GO:0019226) | 2.83394050 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.83057550 |
| 119 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.82825982 |
| 120 | positive regulation of potassium ion transport (GO:0043268) | 2.82257887 |
| 121 | GDP-mannose metabolic process (GO:0019673) | 2.81251527 |
| 122 | regulation of membrane repolarization (GO:0060306) | 2.80991754 |
| 123 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.80884181 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80625144 |
| 125 | neuronal ion channel clustering (GO:0045161) | 2.80002492 |
| 126 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.79201376 |
| 127 | neuron-neuron synaptic transmission (GO:0007270) | 2.78638044 |
| 128 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.77956211 |
| 129 | regulation of vesicle fusion (GO:0031338) | 2.77906159 |
| 130 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.77823252 |
| 131 | T cell homeostasis (GO:0043029) | 2.77288758 |
| 132 | neuromuscular process controlling balance (GO:0050885) | 2.76467072 |
| 133 | calcium ion-dependent exocytosis (GO:0017156) | 2.75930196 |
| 134 | regulation of ARF protein signal transduction (GO:0032012) | 2.75101852 |
| 135 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.74631019 |
| 136 | cerebellar Purkinje cell layer development (GO:0021680) | 2.73882574 |
| 137 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.73334877 |
| 138 | cellular response to interleukin-4 (GO:0071353) | 2.73164662 |
| 139 | regulation of mast cell degranulation (GO:0043304) | 2.73133663 |
| 140 | axon cargo transport (GO:0008088) | 2.72788724 |
| 141 | gamma-aminobutyric acid transport (GO:0015812) | 2.72475990 |
| 142 | organelle transport along microtubule (GO:0072384) | 2.72473152 |
| 143 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.72197062 |
| 144 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.72197062 |
| 145 | potassium ion import (GO:0010107) | 2.71543652 |
| 146 | plasma membrane repair (GO:0001778) | 2.70346975 |
| 147 | glycine transport (GO:0015816) | 2.70344869 |
| 148 | positive regulation of membrane potential (GO:0045838) | 2.69709180 |
| 149 | mating behavior (GO:0007617) | 2.69177305 |
| 150 | regulation of interleukin-4 production (GO:0032673) | 2.68879079 |
| 151 | cellular extravasation (GO:0045123) | 2.68133255 |
| 152 | membrane depolarization (GO:0051899) | 2.67172848 |
| 153 | membrane repolarization (GO:0086009) | 2.66965984 |
| 154 | regulation of neurotransmitter secretion (GO:0046928) | 2.66438716 |
| 155 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.66365179 |
| 156 | mast cell activation (GO:0045576) | 2.66044758 |
| 157 | lymphocyte homeostasis (GO:0002260) | 2.65990727 |
| 158 | regulation of leukocyte degranulation (GO:0043300) | 2.65965347 |
| 159 | potassium ion homeostasis (GO:0055075) | 2.65931390 |
| 160 | regulation of postsynaptic membrane potential (GO:0060078) | 2.65840995 |
| 161 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.64647636 |
| 162 | response to auditory stimulus (GO:0010996) | 2.63238167 |
| 163 | cellular response to ATP (GO:0071318) | 2.63215297 |
| 164 | synaptic vesicle endocytosis (GO:0048488) | 2.63151663 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62543690 |
| 166 | T cell receptor signaling pathway (GO:0050852) | 2.62522615 |
| 167 | auditory behavior (GO:0031223) | 2.61484674 |
| 168 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.60753015 |
| 169 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.60753015 |
| 170 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.60698907 |
| 171 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.60495160 |
| 172 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.60350426 |
| 173 | neuronal action potential (GO:0019228) | 2.59884485 |
| 174 | long-term memory (GO:0007616) | 2.59842098 |
| 175 | response to interleukin-4 (GO:0070670) | 2.59207206 |
| 176 | axonal fasciculation (GO:0007413) | 2.59048908 |
| 177 | interferon-gamma production (GO:0032609) | 2.58725776 |
| 178 | striatum development (GO:0021756) | 2.58608762 |
| 179 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.58266780 |
| 180 | gas transport (GO:0015669) | 2.57150638 |
| 181 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.56909692 |
| 182 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.56749097 |
| 183 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.56403859 |
| 184 | regulation of neurotransmitter levels (GO:0001505) | 2.56272817 |
| 185 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.56144216 |
| 186 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.56144216 |
| 187 | negative regulation of microtubule polymerization (GO:0031115) | 2.55737887 |
| 188 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.54700539 |
| 189 | regulation of synaptic plasticity (GO:0048167) | 2.54663282 |
| 190 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.54457447 |
| 191 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54359135 |
| 192 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.53648986 |
| 193 | regulation of erythrocyte differentiation (GO:0045646) | 2.53076239 |
| 194 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.52541008 |
| 195 | N-acetylneuraminate metabolic process (GO:0006054) | 2.52064799 |
| 196 | regulation of T cell tolerance induction (GO:0002664) | 2.52009559 |
| 197 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.50919385 |
| 198 | response to peptidoglycan (GO:0032494) | 2.50823195 |
| 199 | response to type I interferon (GO:0034340) | 2.50418111 |
| 200 | positive regulation of Rap GTPase activity (GO:0032854) | 2.49957297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.45059028 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.37595335 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.35762679 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89166939 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.78195851 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76531627 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66759791 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66560099 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.64775880 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.62345938 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.58375828 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56043234 |
| 13 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.54646180 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.50428996 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.48829467 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48315942 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.45879925 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45708742 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44956355 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44956355 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44563875 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43205111 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.42299987 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38475455 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.35602348 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.34417169 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31137128 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.30933557 |
| 29 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.27114007 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25914641 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24386777 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24261361 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23991382 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22265975 |
| 35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.22264795 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 2.18453765 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.16287413 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.13866844 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12177054 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.08137263 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07266195 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04382185 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02130552 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01595856 |
| 45 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.99678978 |
| 46 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97562463 |
| 47 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97172543 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93931622 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93731940 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93501284 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.93119006 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.90709057 |
| 53 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.85353291 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83096188 |
| 55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.81005487 |
| 56 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.80347374 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79646446 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79309326 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77804606 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77389789 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76571103 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.76080005 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74485308 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74351943 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.67989284 |
| 66 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.67979594 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67013225 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.65015191 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.63652383 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63537861 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62431092 |
| 72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.61638361 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.59511740 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55583118 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54977071 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53287066 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50345600 |
| 78 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49314493 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.46747326 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43023361 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39994954 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39636272 |
| 83 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39174926 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38676416 |
| 85 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38047613 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36466967 |
| 87 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35988625 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35607594 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35581673 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35549333 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34608062 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34447227 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34322567 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34231162 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34048916 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31054202 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30870575 |
| 98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30357871 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29404295 |
| 100 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28517518 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28503174 |
| 102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28027184 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27554547 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27538295 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27373188 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27241498 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27197046 |
| 108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26739026 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26530017 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24883949 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24405838 |
| 112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24256688 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22718927 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22610523 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21153236 |
| 116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20517474 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20086472 |
| 118 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19954700 |
| 119 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19714325 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19501196 |
| 121 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19367204 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19136770 |
| 123 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.18763065 |
| 124 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18636995 |
| 125 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17038945 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16989224 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15994578 |
| 128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15497569 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14971682 |
| 130 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14767761 |
| 131 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.13131520 |
| 132 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11088689 |
| 133 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10621245 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10480655 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10439439 |
| 136 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08473254 |
| 137 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08402038 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08333784 |
| 139 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07903404 |
| 140 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07774599 |
| 141 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07656795 |
| 142 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07133894 |
| 143 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06926026 |
| 144 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05758390 |
| 145 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.05314500 |
| 146 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04901694 |
| 147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03761554 |
| 148 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03665567 |
| 149 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02615326 |
| 150 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.02464502 |
| 151 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02005161 |
| 152 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.01576431 |
| 153 | * AR_19668381_ChIP-Seq_PC3_Human | 1.01379115 |
| 154 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01307011 |
| 155 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00929480 |
| 156 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00675099 |
| 157 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00537787 |
| 158 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98927895 |
| 159 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98486746 |
| 160 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97863553 |
| 161 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.97415241 |
| 162 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97029095 |
| 163 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96962723 |
| 164 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.95772618 |
| 165 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95525572 |
| 166 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95258666 |
| 167 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95149904 |
| 168 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94979880 |
| 169 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93891438 |
| 170 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93455279 |
| 171 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92834312 |
| 172 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92352279 |
| 173 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92146136 |
| 174 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90994857 |
| 175 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.90644762 |
| 176 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89434805 |
| 177 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88437137 |
| 178 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87049626 |
| 179 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86041577 |
| 180 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85698673 |
| 181 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84856275 |
| 182 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84816527 |
| 183 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82903277 |
| 184 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81575411 |
| 185 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.78453055 |
| 186 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78327710 |
| 187 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78137708 |
| 188 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.77921894 |
| 189 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77020726 |
| 190 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.76511902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.96391582 |
| 2 | MP0004270_analgesia | 4.01672105 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.89762083 |
| 4 | MP0003436_decreased_susceptibility_to | 3.87893698 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.83744377 |
| 6 | MP0003880_abnormal_central_pattern | 3.79477902 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.30954638 |
| 8 | MP0005671_abnormal_response_to | 2.93475008 |
| 9 | MP0003303_peritoneal_inflammation | 2.93448397 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.75540906 |
| 11 | MP0009745_abnormal_behavioral_response | 2.67292389 |
| 12 | MP0001800_abnormal_humoral_immune | 2.63701226 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.61137701 |
| 14 | MP0002064_seizures | 2.60291173 |
| 15 | MP0003724_increased_susceptibility_to | 2.59476540 |
| 16 | MP0002822_catalepsy | 2.58398471 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.57903141 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.57666710 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.55190218 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.54390597 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.51068553 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.50701129 |
| 23 | MP0009278_abnormal_bone_marrow | 2.49071696 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.47753318 |
| 25 | MP0009046_muscle_twitch | 2.46701430 |
| 26 | MP0005025_abnormal_response_to | 2.46448121 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.43628923 |
| 28 | MP0005451_abnormal_body_composition | 2.41901413 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.41306375 |
| 30 | MP0002723_abnormal_immune_serum | 2.38896449 |
| 31 | MP0005387_immune_system_phenotype | 2.38243348 |
| 32 | MP0001790_abnormal_immune_system | 2.38243348 |
| 33 | MP0001819_abnormal_immune_cell | 2.37921847 |
| 34 | MP0000751_myopathy | 2.35975035 |
| 35 | MP0002398_abnormal_bone_marrow | 2.33758497 |
| 36 | MP0003329_amyloid_beta_deposits | 2.33533848 |
| 37 | MP0002272_abnormal_nervous_system | 2.32922183 |
| 38 | MP0000703_abnormal_thymus_morphology | 2.30845409 |
| 39 | MP0002419_abnormal_innate_immunity | 2.29949748 |
| 40 | MP0000685_abnormal_immune_system | 2.29637176 |
| 41 | MP0002736_abnormal_nociception_after | 2.23737380 |
| 42 | MP0002572_abnormal_emotion/affect_behav | 2.17447179 |
| 43 | MP0002452_abnormal_antigen_presenting | 2.16846585 |
| 44 | MP0002733_abnormal_thermal_nociception | 2.16498250 |
| 45 | MP0006276_abnormal_autonomic_nervous | 2.10863794 |
| 46 | MP0005423_abnormal_somatic_nervous | 2.08479822 |
| 47 | MP0004947_skin_inflammation | 2.05381794 |
| 48 | MP0002909_abnormal_adrenal_gland | 2.04735778 |
| 49 | MP0001486_abnormal_startle_reflex | 2.04167716 |
| 50 | MP0004858_abnormal_nervous_system | 2.03962935 |
| 51 | MP0010155_abnormal_intestine_physiology | 2.02845281 |
| 52 | MP0001440_abnormal_grooming_behavior | 2.00294951 |
| 53 | MP0001970_abnormal_pain_threshold | 1.98392434 |
| 54 | MP0000716_abnormal_immune_system | 1.95334558 |
| 55 | MP0002722_abnormal_immune_system | 1.92742115 |
| 56 | MP0003866_abnormal_defecation | 1.92444595 |
| 57 | MP0009785_altered_susceptibility_to | 1.91334717 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.90218335 |
| 59 | MP0002405_respiratory_system_inflammati | 1.89047615 |
| 60 | MP0001873_stomach_inflammation | 1.87818700 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.81844307 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.78861486 |
| 63 | MP0002067_abnormal_sensory_capabilities | 1.75878740 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.75689190 |
| 65 | MP0008260_abnormal_autophagy | 1.69673960 |
| 66 | MP0008569_lethality_at_weaning | 1.69275190 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.68661856 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.68661856 |
| 69 | MP0002429_abnormal_blood_cell | 1.68147838 |
| 70 | MP0002184_abnormal_innervation | 1.68072660 |
| 71 | MP0000778_abnormal_nervous_system | 1.67365768 |
| 72 | MP0005410_abnormal_fertilization | 1.66116849 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.65168724 |
| 74 | MP0001851_eye_inflammation | 1.59863803 |
| 75 | MP0002009_preneoplasia | 1.58624534 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.55451526 |
| 77 | MP0000955_abnormal_spinal_cord | 1.54834441 |
| 78 | MP0004215_abnormal_myocardial_fiber | 1.52407902 |
| 79 | MP0004811_abnormal_neuron_physiology | 1.52106541 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.51621732 |
| 81 | MP0003879_abnormal_hair_cell | 1.50957235 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 1.47216545 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.46904894 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.46187514 |
| 85 | MP0004381_abnormal_hair_follicle | 1.45780371 |
| 86 | MP0005386_behavior/neurological_phenoty | 1.45415708 |
| 87 | MP0004924_abnormal_behavior | 1.45415708 |
| 88 | MP0001529_abnormal_vocalization | 1.45178221 |
| 89 | MP0004036_abnormal_muscle_relaxation | 1.43482849 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.42035306 |
| 91 | MP0002148_abnormal_hypersensitivity_rea | 1.41437605 |
| 92 | MP0000747_muscle_weakness | 1.37742246 |
| 93 | MP0004885_abnormal_endolymph | 1.36639133 |
| 94 | MP0001905_abnormal_dopamine_level | 1.36353691 |
| 95 | MP0002882_abnormal_neuron_morphology | 1.36094826 |
| 96 | MP0002557_abnormal_social/conspecific_i | 1.35883623 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 1.34942056 |
| 98 | MP0000920_abnormal_myelination | 1.34689886 |
| 99 | MP0004084_abnormal_cardiac_muscle | 1.31503532 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 1.30939448 |
| 101 | MP0003137_abnormal_impulse_conducting | 1.30919037 |
| 102 | MP0003633_abnormal_nervous_system | 1.30351422 |
| 103 | MP0000749_muscle_degeneration | 1.30306254 |
| 104 | MP0003646_muscle_fatigue | 1.30211207 |
| 105 | MP0000013_abnormal_adipose_tissue | 1.24489705 |
| 106 | MP0004085_abnormal_heartbeat | 1.24468900 |
| 107 | MP0002166_altered_tumor_susceptibility | 1.22433812 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 1.22239802 |
| 109 | MP0005646_abnormal_pituitary_gland | 1.19596849 |
| 110 | MP0002229_neurodegeneration | 1.17289146 |
| 111 | MP0004043_abnormal_pH_regulation | 1.17255293 |
| 112 | MP0003634_abnormal_glial_cell | 1.15516271 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 1.10924820 |
| 114 | MP0003631_nervous_system_phenotype | 1.09648327 |
| 115 | MP0006082_CNS_inflammation | 1.09351679 |
| 116 | MP0001984_abnormal_olfaction | 1.08863708 |
| 117 | MP0009840_abnormal_foam_cell | 1.08664156 |
| 118 | MP0004142_abnormal_muscle_tone | 1.08496938 |
| 119 | MP0004185_abnormal_adipocyte_glucose | 1.08023990 |
| 120 | MP0008961_abnormal_basal_metabolism | 1.07131192 |
| 121 | MP0000858_altered_metastatic_potential | 1.06499176 |
| 122 | MP0003283_abnormal_digestive_organ | 1.05676879 |
| 123 | MP0008469_abnormal_protein_level | 1.05348766 |
| 124 | MP0003828_pulmonary_edema | 1.03182705 |
| 125 | MP0002132_abnormal_respiratory_system | 1.02916091 |
| 126 | MP0005623_abnormal_meninges_morphology | 1.02841762 |
| 127 | MP0000678_abnormal_parathyroid_gland | 1.01316754 |
| 128 | MP0001485_abnormal_pinna_reflex | 0.97982841 |
| 129 | MP0004742_abnormal_vestibular_system | 0.96511820 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.96191776 |
| 131 | MP0005620_abnormal_muscle_contractility | 0.96055417 |
| 132 | MP0000604_amyloidosis | 0.95572693 |
| 133 | MP0005310_abnormal_salivary_gland | 0.93637603 |
| 134 | MP0002972_abnormal_cardiac_muscle | 0.93544163 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.93032464 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.92472753 |
| 137 | MP0002152_abnormal_brain_morphology | 0.91668329 |
| 138 | MP0004510_myositis | 0.90974889 |
| 139 | MP0005535_abnormal_body_temperature | 0.90306283 |
| 140 | MP0003122_maternal_imprinting | 0.89095093 |
| 141 | MP0004130_abnormal_muscle_cell | 0.88827494 |
| 142 | MP0005083_abnormal_biliary_tract | 0.86693051 |
| 143 | MP0004233_abnormal_muscle_weight | 0.86403701 |
| 144 | MP0005330_cardiomyopathy | 0.84688910 |
| 145 | MP0002069_abnormal_eating/drinking_beha | 0.83455520 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.83272620 |
| 147 | MP0004087_abnormal_muscle_fiber | 0.82029899 |
| 148 | MP0008874_decreased_physiological_sensi | 0.81606600 |
| 149 | MP0000490_abnormal_crypts_of | 0.80012499 |
| 150 | MP0002752_abnormal_somatic_nervous | 0.79948017 |
| 151 | MP0001663_abnormal_digestive_system | 0.79796963 |
| 152 | MP0004147_increased_porphyrin_level | 0.79586118 |
| 153 | MP0010386_abnormal_urinary_bladder | 0.79541697 |
| 154 | MP0004484_altered_response_of | 0.79322977 |
| 155 | MP0003632_abnormal_nervous_system | 0.78871971 |
| 156 | MP0002106_abnormal_muscle_physiology | 0.78202943 |
| 157 | MP0003787_abnormal_imprinting | 0.77658671 |
| 158 | MP0002269_muscular_atrophy | 0.77577237 |
| 159 | MP0002933_joint_inflammation | 0.76048502 |
| 160 | MP0000759_abnormal_skeletal_muscle | 0.75999881 |
| 161 | MP0003453_abnormal_keratinocyte_physiol | 0.75798559 |
| 162 | MP0003448_altered_tumor_morphology | 0.75258754 |
| 163 | MP0002019_abnormal_tumor_incidence | 0.73972497 |
| 164 | MP0005621_abnormal_cell_physiology | 0.71451019 |
| 165 | MP0005551_abnormal_eye_electrophysiolog | 0.71322272 |
| 166 | MP0003690_abnormal_glial_cell | 0.70916021 |
| 167 | MP0009764_decreased_sensitivity_to | 0.70898270 |
| 168 | MP0005369_muscle_phenotype | 0.70364470 |
| 169 | MP0001348_abnormal_lacrimal_gland | 0.70050564 |
| 170 | MP0001963_abnormal_hearing_physiology | 0.67548131 |
| 171 | MP0001986_abnormal_taste_sensitivity | 0.67014028 |
| 172 | MP0000681_abnormal_thyroid_gland | 0.66535766 |
| 173 | MP0002234_abnormal_pharynx_morphology | 0.66393430 |
| 174 | MP0002751_abnormal_autonomic_nervous | 0.66178753 |
| 175 | MP0005666_abnormal_adipose_tissue | 0.64410606 |
| 176 | MP0003045_fibrosis | 0.64356356 |
| 177 | MP0005166_decreased_susceptibility_to | 0.64070074 |
| 178 | MP0003091_abnormal_cell_migration | 0.63891119 |
| 179 | MP0001849_ear_inflammation | 0.63736095 |
| 180 | MP0002006_tumorigenesis | 0.62931051 |
| 181 | MP0005075_abnormal_melanosome_morpholog | 0.62166787 |
| 182 | MP0005390_skeleton_phenotype | 0.61722739 |
| 183 | MP0009931_abnormal_skin_appearance | 0.61285950 |
| 184 | MP0001853_heart_inflammation | 0.60944243 |
| 185 | MP0009765_abnormal_xenobiotic_induced | 0.60789350 |
| 186 | MP0000470_abnormal_stomach_morphology | 0.60009913 |
| 187 | MP0003075_altered_response_to | 0.59584001 |
| 188 | MP0009763_increased_sensitivity_to | 0.57168131 |
| 189 | MP0003795_abnormal_bone_structure | 0.56267442 |
| 190 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54551689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.87216971 |
| 2 | Myokymia (HP:0002411) | 5.35609032 |
| 3 | Visual hallucinations (HP:0002367) | 4.87075864 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.73858081 |
| 5 | Focal seizures (HP:0007359) | 4.62375993 |
| 6 | Stomatitis (HP:0010280) | 4.34082539 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.91235062 |
| 8 | Prolonged bleeding time (HP:0003010) | 3.79734117 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 3.75963360 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.73735318 |
| 11 | Absence seizures (HP:0002121) | 3.57738886 |
| 12 | Pheochromocytoma (HP:0002666) | 3.56781575 |
| 13 | Action tremor (HP:0002345) | 3.56416119 |
| 14 | Myositis (HP:0100614) | 3.48746794 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47847376 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.37610736 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.35341836 |
| 18 | Ankle clonus (HP:0011448) | 3.34216042 |
| 19 | Increased IgE level (HP:0003212) | 3.32936318 |
| 20 | Sudden death (HP:0001699) | 3.32263560 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29144642 |
| 22 | Obstructive lung disease (HP:0006536) | 3.29144642 |
| 23 | Myopathic facies (HP:0002058) | 3.27220255 |
| 24 | Pustule (HP:0200039) | 3.23626127 |
| 25 | Hypochromic anemia (HP:0001931) | 3.20521384 |
| 26 | Dialeptic seizures (HP:0011146) | 3.18954499 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.16799622 |
| 28 | Atonic seizures (HP:0010819) | 3.15779981 |
| 29 | Ventricular fibrillation (HP:0001663) | 3.14748598 |
| 30 | Neurofibrillary tangles (HP:0002185) | 3.13403445 |
| 31 | Abnormality of the fingertips (HP:0001211) | 3.13394006 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.07537490 |
| 33 | Progressive cerebellar ataxia (HP:0002073) | 3.06958416 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.06066708 |
| 35 | Neuroendocrine neoplasm (HP:0100634) | 3.04366555 |
| 36 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.04004773 |
| 37 | Abnormality of DNA repair (HP:0003254) | 3.01410833 |
| 38 | Epileptic encephalopathy (HP:0200134) | 2.98775703 |
| 39 | Recurrent viral infections (HP:0004429) | 2.87731464 |
| 40 | Termporal pattern (HP:0011008) | 2.86926601 |
| 41 | Insidious onset (HP:0003587) | 2.86926601 |
| 42 | Meningitis (HP:0001287) | 2.85027292 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.84733291 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.84697777 |
| 45 | Generalized tonic-clonic seizures (HP:0002069) | 2.83381315 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.81318954 |
| 47 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.80101429 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 2.79039164 |
| 49 | Epistaxis (HP:0000421) | 2.78438437 |
| 50 | Exercise-induced myalgia (HP:0003738) | 2.77323993 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.73365702 |
| 52 | Bundle branch block (HP:0011710) | 2.72855810 |
| 53 | Colitis (HP:0002583) | 2.71848853 |
| 54 | Seborrheic dermatitis (HP:0001051) | 2.68756957 |
| 55 | Depression (HP:0000716) | 2.68502675 |
| 56 | Cellulitis (HP:0100658) | 2.68168584 |
| 57 | T lymphocytopenia (HP:0005403) | 2.67768012 |
| 58 | Hyporeflexia of lower limbs (HP:0002600) | 2.66337219 |
| 59 | Granulocytopenia (HP:0001913) | 2.65697947 |
| 60 | Urinary urgency (HP:0000012) | 2.64827655 |
| 61 | Prolonged QT interval (HP:0001657) | 2.64766996 |
| 62 | Spastic gait (HP:0002064) | 2.63141143 |
| 63 | Orchitis (HP:0100796) | 2.63081873 |
| 64 | Truncus arteriosus (HP:0001660) | 2.62990057 |
| 65 | Encephalitis (HP:0002383) | 2.62743102 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.61623780 |
| 67 | Polycythemia (HP:0001901) | 2.61285294 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.60854371 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.57354314 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.57354314 |
| 71 | Rapidly progressive (HP:0003678) | 2.55749778 |
| 72 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.54183496 |
| 73 | Syncope (HP:0001279) | 2.53313012 |
| 74 | Reticulocytosis (HP:0001923) | 2.53171739 |
| 75 | Dysmetria (HP:0001310) | 2.52918573 |
| 76 | Abnormality of T cells (HP:0002843) | 2.51839586 |
| 77 | Febrile seizures (HP:0002373) | 2.49699342 |
| 78 | Thoracic kyphosis (HP:0002942) | 2.49264164 |
| 79 | Ulnar claw (HP:0001178) | 2.49059940 |
| 80 | Hypertensive crisis (HP:0100735) | 2.48704133 |
| 81 | Microcytic anemia (HP:0001935) | 2.47761748 |
| 82 | Truncal ataxia (HP:0002078) | 2.46486197 |
| 83 | Petechiae (HP:0000967) | 2.45294439 |
| 84 | Anxiety (HP:0000739) | 2.44877639 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.44419863 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 2.44149428 |
| 87 | Calf muscle hypertrophy (HP:0008981) | 2.42648209 |
| 88 | Optic neuritis (HP:0100653) | 2.42112548 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.42112548 |
| 90 | Cholecystitis (HP:0001082) | 2.41123631 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.41123631 |
| 92 | Postural instability (HP:0002172) | 2.40821261 |
| 93 | Basal cell carcinoma (HP:0002671) | 2.39322564 |
| 94 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.37128425 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.35839242 |
| 96 | Abnormality of T cell number (HP:0011839) | 2.35490336 |
| 97 | Papilledema (HP:0001085) | 2.35048788 |
| 98 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.34103144 |
| 99 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.34103144 |
| 100 | Abnormality of T cell physiology (HP:0011840) | 2.33970546 |
| 101 | Vasculitis (HP:0002633) | 2.33422268 |
| 102 | Onion bulb formation (HP:0003383) | 2.32204834 |
| 103 | Agammaglobulinemia (HP:0004432) | 2.31978645 |
| 104 | Hyperthyroidism (HP:0000836) | 2.29132273 |
| 105 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.29112347 |
| 106 | Absent/shortened dynein arms (HP:0200106) | 2.29112347 |
| 107 | Chest pain (HP:0100749) | 2.27106135 |
| 108 | Slow saccadic eye movements (HP:0000514) | 2.26975721 |
| 109 | Abnormality of the lower motor neuron (HP:0002366) | 2.26258172 |
| 110 | Recurrent skin infections (HP:0001581) | 2.24886657 |
| 111 | Abnormality of the calf musculature (HP:0001430) | 2.24340646 |
| 112 | Abnormality of the thoracic spine (HP:0100711) | 2.24102438 |
| 113 | Gaze-evoked nystagmus (HP:0000640) | 2.23083205 |
| 114 | Abnormal EKG (HP:0003115) | 2.22536233 |
| 115 | Urticaria (HP:0001025) | 2.22444646 |
| 116 | Dysdiadochokinesis (HP:0002075) | 2.21566987 |
| 117 | Bowel incontinence (HP:0002607) | 2.21541515 |
| 118 | Lower limb muscle weakness (HP:0007340) | 2.19510966 |
| 119 | Abnormal eating behavior (HP:0100738) | 2.18725270 |
| 120 | Autoimmune hemolytic anemia (HP:0001890) | 2.18664845 |
| 121 | Abnormal platelet volume (HP:0011876) | 2.17258951 |
| 122 | Poor eye contact (HP:0000817) | 2.16745452 |
| 123 | Metaphyseal cupping (HP:0003021) | 2.16087057 |
| 124 | Intention tremor (HP:0002080) | 2.15836712 |
| 125 | Hammertoe (HP:0001765) | 2.13516486 |
| 126 | Hypoproteinemia (HP:0003075) | 2.12804116 |
| 127 | Peripheral hypomyelination (HP:0007182) | 2.12419919 |
| 128 | Hypoplasia of the brainstem (HP:0002365) | 2.12385578 |
| 129 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.12385578 |
| 130 | Increased circulating renin level (HP:0000848) | 2.12057945 |
| 131 | Severe combined immunodeficiency (HP:0004430) | 2.11637376 |
| 132 | Gingivitis (HP:0000230) | 2.11103938 |
| 133 | Fetal akinesia sequence (HP:0001989) | 2.09623092 |
| 134 | Atrial fibrillation (HP:0005110) | 2.09243224 |
| 135 | Verrucae (HP:0200043) | 2.08615666 |
| 136 | Papilloma (HP:0012740) | 2.08615666 |
| 137 | Difficulty running (HP:0009046) | 2.08581867 |
| 138 | Abnormal platelet function (HP:0011869) | 2.08300277 |
| 139 | Impaired platelet aggregation (HP:0003540) | 2.08300277 |
| 140 | Impaired social interactions (HP:0000735) | 2.07895650 |
| 141 | Abnormal social behavior (HP:0012433) | 2.07895650 |
| 142 | Increased serum ferritin (HP:0003281) | 2.07601308 |
| 143 | Keratoconjunctivitis sicca (HP:0001097) | 2.06986558 |
| 144 | Foot dorsiflexor weakness (HP:0009027) | 2.06943284 |
| 145 | Abnormal large intestine physiology (HP:0012700) | 2.06079109 |
| 146 | Leukocytosis (HP:0001974) | 2.06065747 |
| 147 | Primary atrial arrhythmia (HP:0001692) | 2.05762010 |
| 148 | Fatigue (HP:0012378) | 2.05285689 |
| 149 | Limb dystonia (HP:0002451) | 2.04857914 |
| 150 | Reduced antithrombin III activity (HP:0001976) | 2.04377006 |
| 151 | Myotonia (HP:0002486) | 2.04006275 |
| 152 | Purpura (HP:0000979) | 2.03838598 |
| 153 | Annular pancreas (HP:0001734) | 2.03338152 |
| 154 | Muscle fiber splitting (HP:0003555) | 2.01276785 |
| 155 | Akinesia (HP:0002304) | 2.00502878 |
| 156 | Amblyopia (HP:0000646) | 1.99573072 |
| 157 | Agitation (HP:0000713) | 1.99229094 |
| 158 | Hypercortisolism (HP:0001578) | 1.98529084 |
| 159 | Steppage gait (HP:0003376) | 1.97683897 |
| 160 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.97346215 |
| 161 | Gastrointestinal stroma tumor (HP:0100723) | 1.97058159 |
| 162 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97052857 |
| 163 | Thin bony cortex (HP:0002753) | 1.96867851 |
| 164 | Broad-based gait (HP:0002136) | 1.96634879 |
| 165 | Abnormality of the foot musculature (HP:0001436) | 1.96554958 |
| 166 | Torticollis (HP:0000473) | 1.96188684 |
| 167 | Scanning speech (HP:0002168) | 1.94587801 |
| 168 | Dysmetric saccades (HP:0000641) | 1.92134072 |
| 169 | Arterial thrombosis (HP:0004420) | 1.91706069 |
| 170 | Ventricular arrhythmia (HP:0004308) | 1.91542820 |
| 171 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.89345137 |
| 172 | Increased IgM level (HP:0003496) | 1.89266079 |
| 173 | Supraventricular tachycardia (HP:0004755) | 1.88557261 |
| 174 | Neuronal loss in central nervous system (HP:0002529) | 1.86958230 |
| 175 | Neoplasm of the heart (HP:0100544) | 1.86908628 |
| 176 | Cholelithiasis (HP:0001081) | 1.86661538 |
| 177 | Gingival bleeding (HP:0000225) | 1.85361823 |
| 178 | Abnormality of binocular vision (HP:0011514) | 1.85352819 |
| 179 | Diplopia (HP:0000651) | 1.85352819 |
| 180 | Mutism (HP:0002300) | 1.84518507 |
| 181 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.83910912 |
| 182 | Supraventricular arrhythmia (HP:0005115) | 1.83060704 |
| 183 | Oligomenorrhea (HP:0000876) | 1.82505171 |
| 184 | Hypergammaglobulinemia (HP:0010702) | 1.81648122 |
| 185 | Hemiparesis (HP:0001269) | 1.81497652 |
| 186 | Psychosis (HP:0000709) | 1.81104258 |
| 187 | EEG with generalized epileptiform discharges (HP:0011198) | 1.81007277 |
| 188 | Epileptiform EEG discharges (HP:0011182) | 1.80738411 |
| 189 | Type II lissencephaly (HP:0007260) | 1.80559093 |
| 190 | Episodic fever (HP:0001954) | 1.80403590 |
| 191 | Abnormality of iron homeostasis (HP:0011031) | 1.80371389 |
| 192 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.80273055 |
| 193 | Bradycardia (HP:0001662) | 1.80139695 |
| 194 | Rigidity (HP:0002063) | 1.80067300 |
| 195 | Decreased motor nerve conduction velocity (HP:0003431) | 1.79884157 |
| 196 | Lymphopenia (HP:0001888) | 1.79183905 |
| 197 | Retinal dysplasia (HP:0007973) | 1.78942362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.45494323 |
| 2 | NTRK3 | 3.42460968 |
| 3 | MAP3K9 | 3.31233414 |
| 4 | NTRK1 | 2.59199501 |
| 5 | PRKD3 | 2.54802711 |
| 6 | EPHA4 | 2.53453586 |
| 7 | ZAP70 | 2.43235708 |
| 8 | MINK1 | 2.33217231 |
| 9 | MARK1 | 2.29318912 |
| 10 | WNK4 | 2.29037446 |
| 11 | KSR2 | 2.28091249 |
| 12 | STK39 | 2.20157797 |
| 13 | PAK6 | 2.19499036 |
| 14 | ERN1 | 2.16116482 |
| 15 | MAP3K4 | 2.11581255 |
| 16 | MAP2K3 | 2.09630832 |
| 17 | LMTK2 | 2.07883256 |
| 18 | GRK6 | 2.02809611 |
| 19 | JAK3 | 1.99321519 |
| 20 | CDK12 | 1.96295038 |
| 21 | TXK | 1.94330732 |
| 22 | TNK2 | 1.93275806 |
| 23 | PHKG1 | 1.90040502 |
| 24 | PHKG2 | 1.90040502 |
| 25 | TYK2 | 1.84238696 |
| 26 | BTK | 1.83794067 |
| 27 | IKBKE | 1.79481131 |
| 28 | SMG1 | 1.70431345 |
| 29 | NTRK2 | 1.63866464 |
| 30 | ARAF | 1.59068723 |
| 31 | BLK | 1.58573241 |
| 32 | MAP3K12 | 1.54462093 |
| 33 | SYK | 1.52106349 |
| 34 | UHMK1 | 1.51720161 |
| 35 | DAPK2 | 1.51446098 |
| 36 | OXSR1 | 1.51308782 |
| 37 | TAOK3 | 1.49393013 |
| 38 | MAP2K4 | 1.48748973 |
| 39 | PDK3 | 1.47837413 |
| 40 | PDK4 | 1.47837413 |
| 41 | WNK1 | 1.45802918 |
| 42 | MAP3K2 | 1.43402225 |
| 43 | MAP3K14 | 1.40778077 |
| 44 | FGFR4 | 1.37950157 |
| 45 | PAK3 | 1.36681226 |
| 46 | EEF2K | 1.35723101 |
| 47 | CDK5 | 1.35688885 |
| 48 | TYRO3 | 1.33288723 |
| 49 | STK38 | 1.33168101 |
| 50 | ITK | 1.32769852 |
| 51 | CAMKK1 | 1.31783033 |
| 52 | GRK5 | 1.29287605 |
| 53 | MAP2K7 | 1.27262216 |
| 54 | HCK | 1.27120571 |
| 55 | SIK1 | 1.26698324 |
| 56 | PNCK | 1.25125204 |
| 57 | RET | 1.24734476 |
| 58 | MUSK | 1.23652706 |
| 59 | MAP3K6 | 1.22952668 |
| 60 | TNIK | 1.22869393 |
| 61 | SIK3 | 1.22498467 |
| 62 | IRAK4 | 1.16727869 |
| 63 | CSK | 1.15326109 |
| 64 | JAK1 | 1.13056762 |
| 65 | JAK2 | 1.11934741 |
| 66 | LCK | 1.05992281 |
| 67 | MAP3K11 | 1.04297080 |
| 68 | ICK | 1.02734045 |
| 69 | TBK1 | 1.02161763 |
| 70 | MARK2 | 1.02144153 |
| 71 | KSR1 | 1.01646126 |
| 72 | SGK494 | 1.01465863 |
| 73 | SGK223 | 1.01465863 |
| 74 | PINK1 | 0.98909877 |
| 75 | PRPF4B | 0.98687256 |
| 76 | PRKCH | 0.98676447 |
| 77 | WNK3 | 0.98183173 |
| 78 | NEK9 | 0.97828723 |
| 79 | PTK2B | 0.96960316 |
| 80 | HIPK2 | 0.96821160 |
| 81 | MAP3K13 | 0.96697234 |
| 82 | CAMK2A | 0.95876554 |
| 83 | MAPK12 | 0.95365703 |
| 84 | CLK1 | 0.95108903 |
| 85 | TAOK2 | 0.94583579 |
| 86 | IKBKB | 0.93052205 |
| 87 | RIPK4 | 0.92864623 |
| 88 | PTK6 | 0.92821113 |
| 89 | MAP3K10 | 0.91369291 |
| 90 | CDK19 | 0.89533930 |
| 91 | PKN2 | 0.88890792 |
| 92 | LYN | 0.86885709 |
| 93 | EPHB1 | 0.86208863 |
| 94 | BMX | 0.86184142 |
| 95 | MAP3K1 | 0.85152996 |
| 96 | TAOK1 | 0.85128557 |
| 97 | MARK3 | 0.84616011 |
| 98 | TESK2 | 0.84362989 |
| 99 | MAPK13 | 0.83892302 |
| 100 | SIK2 | 0.83543811 |
| 101 | LIMK1 | 0.82455996 |
| 102 | PRKCG | 0.81806360 |
| 103 | MAP2K2 | 0.81312021 |
| 104 | CDK14 | 0.80664951 |
| 105 | STK11 | 0.79622607 |
| 106 | NEK1 | 0.79173313 |
| 107 | CASK | 0.78421676 |
| 108 | CDK18 | 0.77966858 |
| 109 | CAMK2D | 0.77964830 |
| 110 | FGFR2 | 0.77821478 |
| 111 | CDK15 | 0.77598181 |
| 112 | LATS2 | 0.77047939 |
| 113 | CAMK2B | 0.75287247 |
| 114 | CSNK1G2 | 0.74785628 |
| 115 | FER | 0.74239197 |
| 116 | RPS6KL1 | 0.73768247 |
| 117 | RPS6KC1 | 0.73768247 |
| 118 | CSF1R | 0.73493584 |
| 119 | PDPK1 | 0.72615793 |
| 120 | FES | 0.72209412 |
| 121 | CAMK1 | 0.70679552 |
| 122 | PDK1 | 0.70379164 |
| 123 | MAPKAPK5 | 0.69360750 |
| 124 | CDC42BPA | 0.69004204 |
| 125 | TEC | 0.68260243 |
| 126 | CAMKK2 | 0.67822968 |
| 127 | CDK11A | 0.66670638 |
| 128 | PDGFRA | 0.66418066 |
| 129 | PKN1 | 0.65439514 |
| 130 | RIPK1 | 0.64574021 |
| 131 | FGFR3 | 0.63675632 |
| 132 | PIM1 | 0.63271747 |
| 133 | ROCK2 | 0.62187473 |
| 134 | PDK2 | 0.61675858 |
| 135 | DYRK1B | 0.60254380 |
| 136 | CDK4 | 0.59229145 |
| 137 | PRKCE | 0.59209131 |
| 138 | DMPK | 0.58937169 |
| 139 | MAPK11 | 0.58451936 |
| 140 | MAP3K7 | 0.58321879 |
| 141 | FGR | 0.57042854 |
| 142 | RPS6KA6 | 0.57036073 |
| 143 | PRKD1 | 0.56815701 |
| 144 | MAP3K3 | 0.56113138 |
| 145 | MAPK7 | 0.56096102 |
| 146 | MAP2K1 | 0.56003020 |
| 147 | CAMK2G | 0.55633240 |
| 148 | EPHA3 | 0.55607983 |
| 149 | RPS6KA2 | 0.54711821 |
| 150 | TESK1 | 0.53024409 |
| 151 | SGK1 | 0.51908187 |
| 152 | LRRK2 | 0.51565966 |
| 153 | CAMK1D | 0.51179981 |
| 154 | CAMK1G | 0.50507986 |
| 155 | PRKD2 | 0.49739363 |
| 156 | ROCK1 | 0.49179945 |
| 157 | KIT | 0.47979821 |
| 158 | IRAK3 | 0.46767611 |
| 159 | TTN | 0.46370883 |
| 160 | FYN | 0.45626349 |
| 161 | TRIB3 | 0.45260162 |
| 162 | GRK7 | 0.44903407 |
| 163 | BRD4 | 0.44124540 |
| 164 | STK10 | 0.43804622 |
| 165 | * MAPK10 | 0.42997875 |
| 166 | RAF1 | 0.42281117 |
| 167 | MAP2K6 | 0.42259294 |
| 168 | MAPK3 | 0.39826815 |
| 169 | PRKCQ | 0.39474369 |
| 170 | YES1 | 0.38726254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.90886514 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.56317458 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.56230280 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.53096067 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.46069193 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.37629109 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.34257199 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29227308 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.21555634 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.20413080 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.14102053 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.06867710 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.06512295 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05933310 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.03949610 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02570514 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.97991165 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94948346 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.93604617 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.92970962 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.92565417 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90066427 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.89495166 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.88439323 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.82593089 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.81517994 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.80603026 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72674351 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.72156803 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.70829064 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67577287 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67399459 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63934160 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.63227980 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60465965 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58127343 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.56165658 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55157624 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.55002007 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50535476 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.45822431 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42027069 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41887332 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39659107 |
| 45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39098463 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.37476707 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.35522955 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35398974 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34389575 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33503850 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 1.32519717 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32141213 |
| 53 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27649215 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26916970 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26817087 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.25315809 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24805207 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 1.23000527 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21300811 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19371707 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 1.18005866 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16643581 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16439289 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 1.14683016 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12381742 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12065370 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 1.12036525 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 1.11415095 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11174472 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07404633 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06649744 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06623803 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06392055 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05906046 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05612619 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04740789 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 1.03121945 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01460933 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01163929 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97989982 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97611396 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97522771 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.96543073 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95523089 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95168185 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.94635870 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90358449 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.89698753 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89445513 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89198058 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89070424 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.87829752 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87232251 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86849746 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84590196 |
| 96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82302797 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81708702 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80699566 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79005589 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.78607415 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78267155 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.78068718 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77982963 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76551665 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76323186 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75977964 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75660191 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75123282 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74768857 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74763868 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74227416 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73575271 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73196091 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.72255037 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71543781 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70930432 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70635229 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.70267887 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65799768 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65751320 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64829693 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64305036 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64199742 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63573809 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62407379 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.61906430 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61109621 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58473866 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56961151 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56871291 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56108277 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55834801 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54785195 |
| 134 | Bile secretion_Homo sapiens_hsa04976 | 0.52986912 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.52572827 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51618206 |
| 137 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51294306 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50166875 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50137605 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49971425 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49735616 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49721173 |
| 143 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49478885 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48947839 |
| 145 | Phototransduction_Homo sapiens_hsa04744 | 0.48572780 |
| 146 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48145329 |
| 147 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48014935 |
| 148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46400482 |
| 149 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46293330 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46265881 |
| 151 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45678614 |
| 152 | ABC transporters_Homo sapiens_hsa02010 | 0.44937322 |
| 153 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44831961 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.44057361 |
| 155 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43992907 |
| 156 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43622383 |
| 157 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42883298 |
| 158 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42625560 |
| 159 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42506204 |
| 160 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40242770 |
| 161 | Tight junction_Homo sapiens_hsa04530 | 0.39029108 |
| 162 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37351079 |
| 163 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36700256 |
| 164 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35525511 |
| 165 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34632428 |
| 166 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34510063 |
| 167 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33935710 |

